|
Biopharmaceuticals Investment News is an EIN News Service for global investing professionals. Constantly updated news and information about global investing.
Latest Biopharmaceuticals Investment News
- European Commission And Biopharmaceutical Industry Lay Out Steps To Improve Business Environment For Sector SMEs 2 Dec 2009 10:17 GMT
... EBE, the European Biopharmaceutical Enterprises and the European Commission's Enterprise and ... practice in technology transfer and commercialisation; making investments in early stage biopharmaceuticals more attractive via ... venture capital and create world-class expertise in investing in the sector. The workshop attracted around ...
- DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune 2 Dec 2009 12:38 GMT
... "), a biopharmaceutical company that has discovered and is developing ... products, system failures, dependence on key personnel, foreign currency risk, risks related to regulatory matters ... to make decisions with respect to DiaMedica, investors and others should carefully consider the foregoing ...
- Funding crisis 'may force Euro biopharma out of R&D' 2 Dec 2009 09:25 GMT
... force Euro biopharma out of R&D” European biopharmaceutical companies’ existing problems in gaining access to ... they warn policymakers to “be careful” about investing in companies that the financial market has ... in technology transfer and commercialization, and making investments in early-stage biopharmaceuticals more attractive through incentives ...
- Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan 2 Dec 2009 10:02 GMT
... Leader Shabeer Hussain. "However, the lack of investment in the current financial climate has dampened ... to present attractive investment opportunities to large biopharmaceutical companies. Differing regulations are having an impact ... initial investments against the backdrop of the global economic slowdown and heightened cost containment measures, ...
- Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is 2 Dec 2009 10:22 GMT
... Leader Shabeer Hussain. "However, the lack of investment in the current financial climate has dampened ... to present attractive investment opportunities to large biopharmaceutical companies. Differing regulations are having an impact ... initial investments against the backdrop of the global economic slowdown and heightened cost containment measures, ...
- Frost & Sullivan Publishes New Analysis - European Lifestyle Disorders Therapeutics Market 2 Dec 2009 10:41 GMT
... Leader Shabeer Hussain. "However, the lack of investment in the current financial climate has dampened ... to present attractive investment opportunities to large biopharmaceutical companies. Differing regulations are having an impact ... initial investments against the backdrop of the global economic slowdown and heightened cost containment measures, ...
- Shire Settle Litigation Concerning Supply of ADDERALL XR 2 Dec 2009 12:40 GMT
... 2, 2008 - Shire plc , the global specialty biopharmaceutical company, announces that it has settled the ... the parties as part of the settlement. Investor Clea Rosenfeld (Rest of the World) +44 ...
- Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman 2 Dec 2009 08:58 GMT
... Amarin Corporation plc (NASDAQ: ), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, ... of Corporate Business Development where he had global responsibility for licensing activities. Mr. Zakrzewski is ... of the Company's recent financing by top-tier investors, the composition of its Board and the ...
- Future likely to witness improved therapies and novel drugs to treat lifestyle disorders 2 Dec 2009 10:47 GMT
... Leader Shabeer Hussain. "However, the lack of investment in the current financial climate has dampened ... to present attractive investment opportunities to large biopharmaceutical companies. Differing regulations are having an impact ... initial investments against the backdrop of the global economic slowdown and heightened cost containment measures, ...
- Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic 2 Dec 2009 12:34 GMT
... Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has settled the ... Exchange Commission. For further information please contact: Investor Relations: Cléa Rosenfeld (Rest of the World), ...
- Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman (BIZ) 2 Dec 2009 09:05 GMT
... of Corporate Business Development where he had global responsibility for licensing activities. Mr. Zakrzewski is ... of the Company's recent financing by top-tier investors, the composition of its Board and the ... greater than twelve-months. Amarin is a clinical-stage biopharmaceutical company with a focus on cardiovascular disease. ...
- Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman Appointment Reflects Company Focus on Cardiovascular Disease 2 Dec 2009 10:01 GMT
... application for Huntington's Disease ), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, ... of Corporate Business Development where he had global responsibility for licensing activities. Mr. Zakrzewski is ... of the Company's recent financing by top-tier investors, the composition of its Board and the ...
- Thermo Fisher Scientific Announces Millipore has Selected and Implemented Watson LIMS 2 Dec 2009 04:36 GMT
... binding assays that enable the development of biopharmaceuticals and translational biomarker applications. Millipore takes advantage ... information and maximizing a company's enterprise system investments to better support critical management decisions in ... pharmacokinetic and ADME/Tox services," said Craig Morley, global managing director for Millipore's BioPharma Services business. ...
- www.standoutstocks.com: Stocks That Stand Out For Dec. 1st, 2009 Are CBPO, RFMD, EDWY, HTDS, CCTR 1 Dec 2009 17:37 GMT
... the "Company"), one of the leading plasma-based biopharmaceutical companies in China, today announced that the ... on will improve our visibility within the investment community, and lead toward increased liquidity and ... who wish to experience huge profits via investing in up-and-coming publicly traded companies. www.Standoutstocks.com email ...
- Stocks That Stand Out For Dec. 1st, 2009 Are CBPO, RFMD, EDWY, HTDS, CCTR 1 Dec 2009 19:39 GMT
... the "Company"), one of the leading plasma-based biopharmaceutical companies in China, today announced that the ... NASDAQ will improve our visibility within the investment community, and lead toward increased liquidity and ... who wish to experience huge profits via investing in up-and-coming publicly traded companies. www.Standoutstocks.com email ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
|
a digital news provider
abcnews.go.com:
moneyweek.com:
reuters.com: